MarkHEinsteinMD

Obstetrics & Gynecology • Newark, NJ

General Gynecology, General Obstetrics, Gynecologic Oncology

Professor and Chair, Department of Obstetrics, Gynecology, & Women's Health

Join to view full profile

Dr. Einstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Einstein's full profile

Already have an account?

Office
185 S Orange Ave
# Rutgers
Newark, NJ 07103
Phone+1 973-972-5266

Fax+1 973-972-4574

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 1999 - 2002
Rutgers Health/Cooperman Barnabas Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
University of Miami Leonard M. Miller School of MedicineClass of 1995

Certifications & Licensure

NY State Medical License 1999 - 2026
NJ State Medical License 1997 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2013-2015
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia Start of enrollment: 2004 Mar 01
Completed
Phase 2
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Start of enrollment: 2003 Apr 01
Terminated
Phase 2
Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus Start of enrollment: 2003 Feb 01
Completed
Phase 2
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers Start of enrollment: 2004 Nov 01
Completed
Phase 2
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma Start of enrollment: 2001 Dec 01
Completed
Phase 2
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix Start of enrollment: 2006 Jan 01
Completed
Phase 2
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer Start of enrollment: 2007 Aug 01
Terminated
Phase 2
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) Start of enrollment: 2007 Nov 01
Completed
Phase 2
Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2008 Jul 01
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Start of enrollment: 2009 Jan 16
Terminated
Phase 2
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Start of enrollment: 2010 Jan 01
Terminated
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males Start of enrollment: 2011 Jun 28
Completed
Phase 2
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer Start of enrollment: 2014 Apr 01
Completed
Phase 2
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV Start of enrollment: 2013 Dec 04
Completed
Not Applicable
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions Start of enrollment: 2015 Apr 01
Completed
Join now to see all

Publications & Presentations

PubMed

373 citations
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Rebecca B Perkins, Richard S Guido, Philip E Castle, David Chelmow, Mark H Einstein
Journal of Lower Genital Tract Disease. 2020-04-01
148 citations
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
Joel M Palefsky, Jeannette Y Lee, Naomi Jay, Stephen E Goldstone, Teresa M Darragh
The New England Journal of Medicine. 2022-06-16
28 citations
Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy
Jeny Ghartey, Colleen Carpenter, Philip Gialanella, Charlotte Rising, Thomas McAndrew
American Journal of Obstetrics and Gynecology. 2012-10-01

Lectures

Loop Electrosurgical Excision Procedure (LEEP)
American Society for Colposcopy and Cervical Pathology, Phoenix, Arizona - 3/22/2013

Press Mentions

Advanced Cervical Cancer on the Rise in White and Black Women in the USAugust 23rd, 2022
INOVIO to Present at Upcoming Investor Conferences in MarchMarch 2nd, 2021
Prevalence of SARS-CoV-2 Infection in Previously Undiagnosed Health Care Workers in New Jersey, at the Onset of the U.S. COVID-19 PandemicNovember 16th, 2020
Join now to see all